DENNIS BEHLER: Open Payments
NPI 1649593294 · REED CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 58 payments from 18 companies in 2025. Trend: 2023 $769 · 2024 $1,127 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| PFIZER INC. | 13 | $136 |
| Novo Nordisk Inc | 4 | $79 |
| Astellas Pharma US Inc | 4 | $76 |
| Abbott Laboratories | 3 | $58 |
| Lilly USA, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Stryker Corporation | 1 | $34 |
Products named: UBRELVY, Veozah, ELIQUIS, NURTEC ODT, MOUNJARO, TZIELD, JOURNAVX, PROCLAIM.
Industry payments across MI — which companies pay providers there.
